GSK-208136/019 (MeMuRu-OKA-019)

Study to evaluate immunogenicity and safety of one dose of GSK Biologicals’ measles-mumps-rubella-varicella vaccine given to healthy children previously primed with one dose of measles-mumps-rubella vaccine
Combined Measles, Mumps, Rubella, Varicella Vaccine
208136/019 (MeMuRu-OKA-019)
Measles; Mumps; Rubella; Varicella
Phase 3
An annotated case report form is not available for this study. A blank case report form will be provided. A link to and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.
September 2015